24.12.2014 Views

Towards a national health insurance system in ... - Detlef Schwefel

Towards a national health insurance system in ... - Detlef Schwefel

Towards a national health insurance system in ... - Detlef Schwefel

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Towards</strong> a <strong>national</strong> <strong>health</strong> <strong><strong>in</strong>surance</strong> <strong>system</strong> <strong>in</strong> Yemen – Part 1: Background and assessments 45<br />

“There is very little coord<strong>in</strong>ation, at all levels of government, of plans with budgets. Actual spend<strong>in</strong>g<br />

differs, often considerably, from approved budgets, and there is no accountability for budgets or<br />

spend<strong>in</strong>g levels. The representatives of the M<strong>in</strong>istry of F<strong>in</strong>ance seem to exercise a disproportionate<br />

degree of control over spend<strong>in</strong>g at all levels of the government <strong>health</strong> <strong>system</strong>, and the budget<strong>in</strong>g and<br />

disbursement practices do not seem to support implementation needs of government programs. The<br />

tim<strong>in</strong>g of the release of <strong>in</strong>vestment funds is counterproductive to smooth execution of planned<br />

projects, and the release of funds for current operations, requir<strong>in</strong>g <strong>in</strong>voices <strong>in</strong> advance of<br />

disbursement, makes it very difficult for <strong>health</strong> managers to have the resources they need when they<br />

need them.” (Fairbank 2005, p. 25) From the po<strong>in</strong>t of view of <strong>health</strong> professionals recurrent funds are<br />

provided at levels far below requests and needs. From the po<strong>in</strong>t of view of the officials <strong>in</strong> the M<strong>in</strong>istry<br />

of F<strong>in</strong>ance many of the requests are unfounded <strong>in</strong> terms of an effective and efficient expenditure<br />

pattern. The result is a severe under-fund<strong>in</strong>g of public <strong>health</strong> care. (Constable 2002) Ma<strong>in</strong> victims are<br />

the cost-shar<strong>in</strong>g patients who have to compensate for this.<br />

The op<strong>in</strong>ion of the leaders<br />

91 % of op<strong>in</strong>ion leaders say:<br />

Cost-shar<strong>in</strong>g leads to postponement of treatments<br />

63 % of op<strong>in</strong>ion leaders say:<br />

Exempted diseases are not exempted<br />

from cost-shar<strong>in</strong>g<br />

Source: GTZ&EC survey 2005<br />

3.2.5 Health care benefits<br />

Currently, the M<strong>in</strong>istry of Public Health and Population does not def<strong>in</strong>e a benefit package that has to<br />

be provided to the ge neral population by public hospitals, <strong>health</strong> centres or <strong>health</strong> units. The<br />

management of each <strong>in</strong>stitution is thus free to offer a range of benefits as they like - the preferences of<br />

the population were not evaluated, the catalogues are not based on evident needs. In the best case, the<br />

benefit packages might be based on the expertise of the <strong>health</strong> professionals and the available<br />

equipment. In the worst case, the benefits offered are tailored to maximise cost-shar<strong>in</strong>g revenues and<br />

revenues from <strong>in</strong>formal payments <strong>in</strong> a <strong>health</strong> facility. Because of rudimentary and unreliable statistics<br />

on the <strong>health</strong> services actually provided at all levels of the <strong>health</strong> care <strong>system</strong> it is virtually impossible<br />

for the M<strong>in</strong>istry or for an external reviewer to get a picture of the benefits currently provided to the<br />

population without recurr<strong>in</strong>g to major audits. Likewise, utilisation data from the private sector is not<br />

available. Therefore, some proxy measures have to be taken <strong>in</strong>to account to get a rough picture of<br />

benefits and prices of <strong>health</strong> services currently offered to patients <strong>in</strong> Yemen.<br />

The op<strong>in</strong>ion of the leaders<br />

77 % of op<strong>in</strong>ion leaders say:<br />

Drugs should be <strong>in</strong>cluded <strong>in</strong> benefit package of <strong>health</strong> <strong><strong>in</strong>surance</strong><br />

Source: GTZ&EC survey 2005<br />

One proxy measure used here is utilisation data based on <strong>health</strong> surveys. Others <strong>in</strong>clude MoPH&P and<br />

hospital statistics as well as official price lists of hospitals and f<strong>in</strong>ancial statistics from company <strong>health</strong><br />

benefit schemes.<br />

Survey data: Accord<strong>in</strong>g to the Beatty et alii (1998) survey, the majority of <strong>health</strong> care visits <strong>in</strong> the<br />

survey population were for curative care. In rural areas only 0.6 to 2.4% of outpatient visits were for<br />

preventive care. In urban areas, the preventive care was soug ht <strong>in</strong> 6% of visits. The reasons for seek<strong>in</strong>g<br />

care elicited <strong>in</strong> this survey give a rough idea of the demand for <strong>health</strong> services <strong>in</strong> Yemen (Table 21).

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!